These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33758867)

  • 41. Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study.
    Rabie AM; Eltayb WA
    Mol Biotechnol; 2024 Apr; 66(4):592-611. PubMed ID: 36690820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.
    Zhao J; Zhang G; Zhang Y; Yi D; Li Q; Ma L; Guo S; Li X; Guo F; Lin R; Luu G; Liu Z; Wang Y; Cen S
    Antiviral Res; 2021 Dec; 196():105209. PubMed ID: 34801588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
    Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A new insight.
    Esam Z; Akhavan M; Lotfi M; Bekhradnia A
    J Mol Struct; 2022 Jan; 1247():131394. PubMed ID: 34483364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay.
    Uppal T; Tuffo K; Khaiboullina S; Reganti S; Pandori M; Verma SC
    Cell Insight; 2022 Aug; 1(4):100046. PubMed ID: 37192863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.
    Pachetti M; Marini B; Benedetti F; Giudici F; Mauro E; Storici P; Masciovecchio C; Angeletti S; Ciccozzi M; Gallo RC; Zella D; Ippodrino R
    J Transl Med; 2020 Apr; 18(1):179. PubMed ID: 32321524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN.
    Moeller NH; Shi K; Demir Ö; Belica C; Banerjee S; Yin L; Durfee C; Amaro RE; Aihara H
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35165203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin.
    Yin W; Luan X; Li Z; Zhou Z; Wang Q; Gao M; Wang X; Zhou F; Shi J; You E; Liu M; Wang Q; Jiang Y; Jiang H; Xiao G; Zhang L; Yu X; Zhang S; Eric Xu H
    Nat Struct Mol Biol; 2021 Mar; 28(3):319-325. PubMed ID: 33674802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase.
    Ivanov KA; Thiel V; Dobbe JC; van der Meer Y; Snijder EJ; Ziebuhr J
    J Virol; 2004 Jun; 78(11):5619-32. PubMed ID: 15140959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. De Novo Potent Peptide Nucleic Acid Antisense Oligomer Inhibitors Targeting SARS-CoV-2 RNA-Dependent RNA Polymerase via Structure-Guided Drug Design.
    Shehzadi K; Yu M; Liang J
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets.
    Maio N; Lafont BAP; Sil D; Li Y; Bollinger JM; Krebs C; Pierson TC; Linehan WM; Rouault TA
    Science; 2021 Jul; 373(6551):236-241. PubMed ID: 34083449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches.
    Pundir H; Joshi T; Pant M; Bhat S; Pandey J; Chandra S; Tamta S
    J Biomol Struct Dyn; 2022; 40(24):13366-13377. PubMed ID: 34637693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computational Study of Helicase from SARS-CoV-2 in RNA-Free and Engaged Form.
    Di Matteo F; Frumenzio G; Chandramouli B; Grottesi A; Emerson A; Musiani F
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug-Protein Binding.
    Alamri MA; Tahir Ul Qamar M; Alabbas AB; Alqahtani SM; Alossaimi MA; Azam S; Hashmi MH; Rajoka MSR
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
    Dhankhar P; Dalal V; Kumar V
    J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
    Tsuji M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19.
    Chien M; Anderson TK; Jockusch S; Tao C; Li X; Kumar S; Russo JJ; Kirchdoerfer RN; Ju J
    J Proteome Res; 2020 Nov; 19(11):4690-4697. PubMed ID: 32692185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase.
    Xu T; Zhang L
    Comput Struct Biotechnol J; 2023; 21():4385-4394. PubMed ID: 37711189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
    Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of SARS-CoV-2 replication complex elongation and proofreading activity.
    Jones AN; Mourão A; Czarna A; Matsuda A; Fino R; Pyrc K; Sattler M; Popowicz GM
    Sci Rep; 2022 Jun; 12(1):9593. PubMed ID: 35688849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.